Skip to main content
. 2023 Feb 27;2023(2):CD012922. doi: 10.1002/14651858.CD012922.pub2

Comparison 2. Methylxanthine derivative agents versus inactive control .

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
2.1 Central apnoea‐hypopnoea index (short‐term) 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
2.2 Apnoea‐hypopnoea index (short‐term) 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected